Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2014 3
2015 2
2016 4
2017 4
2018 10
2019 8
2020 6
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Wollenweber T, Zisser L, Kretschmer-Chott E, Weber M, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Schmitl S, Vraka C, Haug AR, Hacker M, Hartenbach M, Rasul S. Wollenweber T, et al. Among authors: hartenbach m. Curr Oncol. 2021 Sep 23;28(5):3692-3704. doi: 10.3390/curroncol28050315. Curr Oncol. 2021. PMID: 34590608 Free PMC article.
Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
Rasul S, Hartenbach M, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat S, Wadsak W, Mitterhauser M, Pichler V, Vraka C, Hacker M, Haug AR. Rasul S, et al. Among authors: hartenbach m. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1650-1657. doi: 10.1007/s00259-020-05082-5. Epub 2020 Oct 30. Eur J Nucl Med Mol Imaging. 2021. PMID: 33128131 Free PMC article.
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Aksoy O, Pencik J, Hartenbach M, Moazzami AA, Schlederer M, Balber T, Varady A, Philippe C, Baltzer PA, Mazumder B, Whitchurch JB, Roberts CJ, Haitel A, Herac M, Susani M, Mitterhauser M, Marculescu R, Stangl-Kremser J, Hassler MR, Kramer G, Shariat SF, Turner SD, Tichy B, Oppelt J, Pospisilova S, Hartenbach S, Tangermann S, Egger G, Neubauer HA, Moriggl R, Culig Z, Greiner G, Hoermann G, Hacker M, Heery DM, Merkel O, Kenner L. Aksoy O, et al. Among authors: hartenbach m. Int J Cancer. 2021 Feb 1;148(3):731-747. doi: 10.1002/ijc.33332. Epub 2020 Oct 31. Int J Cancer. 2021. PMID: 33034050 Free PMC article.
Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI.
Rischka L, Gryglewski G, Berroterán-Infante N, Rausch I, James GM, Klöbl M, Sigurdardottir H, Hartenbach M, Hahn A, Wadsak W, Mitterhauser M, Beyer T, Kasper S, Prayer D, Hacker M, Lanzenberger R. Rischka L, et al. Among authors: hartenbach m. Front Physiol. 2019 Nov 22;10:1422. doi: 10.3389/fphys.2019.01422. eCollection 2019. Front Physiol. 2019. PMID: 31824335 Free PMC article.
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
Rasul S, Hacker M, Kretschmer-Chott E, Leisser A, Grubmüller B, Kramer G, Shariat S, Wadsak W, Mitterhauser M, Hartenbach M, Haug AR. Rasul S, et al. Among authors: hartenbach m. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):713-720. doi: 10.1007/s00259-019-04584-1. Epub 2019 Nov 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 31781834 Free PMC article.
Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.
Grubmüller B, Rasul S, Baltzer P, Fajkovic H, D'Andrea D, Berndl F, Maj-Hes A, Grubmüller KH, Mitterhauser M, Wadsak W, Pfaff S, Shariat SF, Hacker M, Kramer G, Hartenbach M. Grubmüller B, et al. Among authors: hartenbach m. Prostate. 2020 Jan;80(1):74-82. doi: 10.1002/pros.23919. Epub 2019 Oct 15. Prostate. 2020. PMID: 31614001
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga]Ga-Pentixafor-PET/MRI.
Haug AR, Leisser A, Wadsak W, Mitterhauser M, Pfaff S, Kropf S, Wester HJ, Hacker M, Hartenbach M, Kiesewetter-Wiederkehr B, Raderer M, Mayerhoefer ME. Haug AR, et al. Among authors: hartenbach m. Theranostics. 2019 May 27;9(12):3653-3658. doi: 10.7150/thno.31032. eCollection 2019. Theranostics. 2019. PMID: 31281504 Free PMC article.
Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.
Abufaraj M, Grubmüller B, Zeitlinger M, Kramer G, Seitz C, Haitel A, Baltzer P, Hacker M, Wadsak W, Pfaff S, Wiatr T, Mitterhauser M, Shariat SF, Hartenbach M. Abufaraj M, et al. Among authors: hartenbach m. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2169-2177. doi: 10.1007/s00259-019-04361-0. Epub 2019 Jun 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 31254037 Free PMC article. Clinical Trial.
34 results